On the 17th, the medical device specialized corporation ACH Medical announced that it has filed a patent infringement lawsuit against Livsmed, which is preparing for its listing on the KOSDAQ market. ACH Medical stated, "We have determined that our domestic registered patents related to medical devices have been infringed by Livsmed," adding, "This is a legitimate legal response to protect our intellectual property rights."
Founded in 2008 under the name BioGenesis, ACH Medical is a corporation that develops and sells laparoscopic surgical equipment and surgical instruments. In particular, it has secured numerous patents related to jointed laparoscopic technology to advance into the cutting-edge laparoscopic field.
ACH Medical is a specialized medical device corporation that possesses multiple quality certifications, including the U.S. Food and Drug Administration's (FDA) 510(k), the European Union's CE certification established for safety and quality assurance, and the international standard ISO 13485 for medical device quality management systems. The company currently exports products to over 30 countries worldwide, with export sales accounting for approximately 90% of its total revenue.
Livsmed, which has been sued for patent infringement by ACH Medical, is a corporation preparing for its listing on the KOSDAQ market. In May, it submitted a request for preliminary examination for listing to the Korea Exchange's KOSDAQ market headquarters. Starting as a medical device development startup, Livsmed has developed surgical instruments, including the 'ArtiSential', which can rotate 90 degrees in all directions. Earlier this year, it was recognized with a corporate value of 880 billion won in a pre-IPO.
An official from ACH Medical explained, "This lawsuit is an inevitable measure to protect the company's core technology and intellectual property rights," adding, "We will actively respond to establish a fair market order based on technological innovation and patent protection in the future."